Immune activation in cervical neoplasia: Cross-sectional association between plasma soluble interleukin 2 receptor levels and disease

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 10, 1997, Pages 807-813

  Hildesheim, Allan ^a   Schiffman, Mark H ^a   Tsukui, Taku ^a   Swanson, Christine A ^a   Lucci III, Joseph ^b   Scott, David R ^c   Glass, Andrew G ^c   Rush, Brenda B ^c   Lorincz, Attila T ^d   Corrigan, Alice ^d   Burk, Robert D ^e   Helgesen, Kay ^f   Houghten, Richard A ^g   Sherman, Mark E ^a,h   Kurman, Robert J ⁱ   Berzofsky, Jay A ^a   Kramer, Tim R ^j  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c KAISER PERMANENTE   (United States)

^d Digene Corporation   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f INFORMATION MANAGEMENT SERVICES INC   (United States)

^g TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^h GEORGE WASHINGTON UNIVERSITY   (United States)

ⁱ JOHNS HOPKINS HOSPITAL   (United States)

^j BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER IMMUNOLOGY; CANCER INVASION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, VIRAL; CROSS-SECTIONAL STUDIES; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-2; TH1 CELLS; TH2 CELLS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 16944365316     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Shah, K. V., and Howley, P. M. Papillomaviruses. In: B. N. Fields, D. M. Knipe, and P. M. Howley (eds.), Fields Virology, pp. 2077-2109. Philadelphia: Raven Press, Ltd., 1996.
2. Schiffman, M. H. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J. Natl. Cancer Inst., 84: 394-398, 1992.
3. Hildesheim, A., Schiffman, M. H., Gravitt, P., Glass, A. G., Greer, C., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., Kurman, R. J., and Manos, M. M. Persistence of type-specific human papillomavirus infection among cytologically normal women in Portland, Oregon. J. Infect. Dis., 169: 235-240, 1994.
4. Nasiell, K., Roger, V., and Nasiell, M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet. Gynecol., 67: 665-669, 1986.
5. Frazer, I. H., and Tindle, R. W. Cell-mediated immunity to papillomaviruses. Papillomavirus Rep., 3: 53-58, 1992.
6. Brandsma, J. L. Animal models for HPV vaccine development. Papillomavirus Rep., 5: 105-111, 1994.
7. Selvakumar, R., Borenstien, L. A., Lin, Y-L., Ahmed, R., and Wettstein, F. O. Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas. J. Virol., 69: 602-605, 1995.
8. Benton, C., Shahidullah, H., and Hunter, J. A. A. Human papillomavirus in the immunosuppressed. Papillomavirus Rep., 3: 23-26, 1992.
9. Edwards, R. P., Kuykendall, K., Crowley-Nowick, P., Partridge, E. E., Shingleton, H. M., and Mestecky, J. T lymphocytes infiltrating advanced grades of cervical neoplasia. CD8-positive cells are recruited to invasion. Cancer (Phila.), 76: 1411-1415, 1995.
10. Iwatsuki, K., Tagami, H., Takigawa, M., and Yamada, M. Plane warts under spontaneous regression. Immunopathologic study on cellular constituents leading to the inflammatory reaction. Arch. Dermatol., 122: 655-659, 1986.
11. Suzich, J. A., Ghim, S. J., Palmer-Hill, F. J., White, W. I., Tamura, J. K., Bell, J. A., Newsome, J. A., Jenson, A. B., and Schlegel, R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci., 92: 11553-11557, 1995.
12. Tay, S. K., Jenkins, D., Maddox, P., Campion, M., and Singer, A. Subpopulations of Langerhans' cells in cervical neoplasia. Br. J. Obstet. Gynaecol., 94: 10-15, 1987.
13. Odunsi, K., Terry, G., Ho, L., Bell, J., Cuzick, J., and Ganesan, T. S. Association between HLA DQB103 and cervical intraepithelial neoplasia. Mol. Med., 1: 161-171, 1995.
14. Apple, R. J., Erlich, H. A., Klitz, W., Manos, M. M., Becker, T. M., and Wheeler, C. M. HLA DR-DQ associations with cervical carcinoma show papil-lomavirus-type specificity. Nat. Genet., 6: 157-162, 1994.
15. Apple, R. J., Becker, T. M., Wheeler, C. M., and Erlich, H. A. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J. Natl. Cancer Inst., 87: 427-436, 1995.
16. Tsukui, T., Hildesheim, A., Schiffman, M. H., Lucci, J., Contois, D., Lawler, P., Rush, B. B., Lorincz, A. T., Corrigan, A., Carbone, D. P., Scott, D. R., Houghten, R. A., and Berzofsky, J. A. IL-2 production by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res., 56: 3967-3974, 1996.
17. Sher, A., Gazzinelli, R. T., Oswald, I. P., Clerici, M., Kullberg, M., Pearce, E. J., Berzofsky, J. A., Mosmann, T. R., James, S. L., Morse, H. C., III, and Shearer, G. M. Role of T-cell derived cytokines in the down-regulation of immune responses in parasitic and retroviral infection. Immunol. Rev., 127: 183-204, 1992.
18. Actor, J. K. D., Shirai, M., Kullberg, M. C., Buller, R. M. L., Sher, A., and Berzofsky, J. A. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc. Natl. Acad. Sci. USA, 90: 948-952, 1993.
19. Romagnani, S. Human Th1 and Th2 subsets: regulation of differentiation and role in protection and immunopathology. Int. Arch. Allergy Immunol., 98: 279-285, 1992.
20. Locksley, R. M. Interleukin 12 in host defense against microbial pathogens. Proc. Natl. Acad. Sci. USA, 90: 5879-5880, 1993.
21. Yamamura, M., Uyemura, K., Deans, R. J., Weinberg, K., Rea, T. H., Bloom, B. R., and Modlin, R. L. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (Washington DC), 254: 277-279, 1991.
22. Clerici, M., and Shearer, G. M. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today, 15: 575-581, 1994.
23. Rubin, L. A., and Nelson, D. L. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann. Intern. Med., 113: 619-627, 1990.
24. Waldmann, T. A. The IL-2/IL-2 receptor system: a target for rational immune intervention. Immunol. Today, 14: 264-270, 1993.
25. Nelson, D. L., Rubin, L. A., Kurman, C. C., Fritz, M. E., and Boutin, B. An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro. J. Clin. Immunol., 6: 114-120, 1986.